Copyright
©The Author(s) 2020.
World J Transplant. May 29, 2020; 10(5): 117-128
Published online May 29, 2020. doi: 10.5500/wjt.v10.i5.117
Published online May 29, 2020. doi: 10.5500/wjt.v10.i5.117
Figure 1 Circulating interleukin-33 levels in recipients immediately following reperfusion.
A: Elevation of interleukin-33 was observed in recipients implanted with moderate macrosteatotic grafts. B and C: Higher levels of both alanine aminotransferase and aspartate transaminase (IU/L) were in recipients with detectable interleukin-33 levels following liver reperfusion. aP < 0.05, bP < 0.01. IL-33: Interleukin-33; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase.
Figure 2 Complement activation in recipients of moderate macrosteatotic grafts.
A: Elevated levels of activated complement C3a was observed in recipients implanted with moderate macrosteatotic grafts immediately following liver reperfusion; B: Elevated levels of activated complement C5a was observed in recipients implanted with moderate macrosteatotic grafts immediately following liver reperfusion. aP < 0.05, bP < 0.01.
- Citation: Núñez K, Hamed M, Fort D, Bruce D, Thevenot P, Cohen A. Links between donor macrosteatosis, interleukin-33 and complement after liver transplantation. World J Transplant 2020; 10(5): 117-128
- URL: https://www.wjgnet.com/2220-3230/full/v10/i5/117.htm
- DOI: https://dx.doi.org/10.5500/wjt.v10.i5.117